Our Clinical Studies
Our Program
Through a proprietary technology, our incisionless treatment leverages a controlled cooling process to reduce tissue and open airways.
Our commitment to improving people’s lives by solving obstructive sleep apnea (OSA) starts with our clinical program.
Cryosa is currently enrolling participants in a U.S. pilot study (ARCTIC-3) to evaluate the
safety and effectiveness of our therapy to treat OSA patients with moderate to severe
disease. Current geographies include New York, Pennsylvania, and Florida, with others soon to follow. Click below to see if there is a site near you.